HPTN 074 Demonstrates Significant Benefits Among People Living with HIV Who Inject Drugs

HPTN 074 Demonstrates Significant Benefits Among People Living with HIV Who Inject Drugs
September 5, 2018 Eric Bosch

More terrific, breaking news from our friends at the HIV Prevention Trials Network. We've had the pleasure of providing data management support for the HPTN 074 trial since January 2015. Congratulations to the investigators and study team.

From the press release: "Investigators from the HIV Prevention Trials Network (HPTN) today announced The Lancet has published key results from HPTN 074. At 52 weeks from enrollment, participants in the intervention arm nearly doubled their antiretroviral therapy usage, viral suppression and medication-assisted treatment usage compared to the standard of care arm. Mortality was also reduced by more than half with the intervention."

Read the full press release on the HPTN website.